WO2023186186A1 - Procédé de préparation d'une enzyme immobilisée ayant une forte stabilité - Google Patents
Procédé de préparation d'une enzyme immobilisée ayant une forte stabilité Download PDFInfo
- Publication number
- WO2023186186A1 WO2023186186A1 PCT/CN2023/095548 CN2023095548W WO2023186186A1 WO 2023186186 A1 WO2023186186 A1 WO 2023186186A1 CN 2023095548 W CN2023095548 W CN 2023095548W WO 2023186186 A1 WO2023186186 A1 WO 2023186186A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- linking agent
- enzyme
- lxte
- cross
- range cross
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- 108010093096 Immobilized Enzymes Proteins 0.000 title claims abstract description 43
- 102000004190 Enzymes Human genes 0.000 claims abstract description 65
- 108090000790 Enzymes Proteins 0.000 claims abstract description 58
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 51
- 239000000243 solution Substances 0.000 claims abstract description 25
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 10
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004327 boric acid Substances 0.000 claims abstract description 8
- SYEWHONLFGZGLK-UHFFFAOYSA-N 2-[1,3-bis(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COCC(OCC1OC1)COCC1CO1 SYEWHONLFGZGLK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004593 Epoxy Substances 0.000 claims abstract description 7
- 229920003180 amino resin Polymers 0.000 claims abstract description 7
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 claims abstract description 6
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 claims abstract description 6
- 229960001327 pyridoxal phosphate Drugs 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 17
- 239000000872 buffer Substances 0.000 claims description 12
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 claims description 9
- 241000894006 Bacteria Species 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000012065 filter cake Substances 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- HSDVRWZKEDRBAG-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COC(CCCCC)OCC1CO1 HSDVRWZKEDRBAG-UHFFFAOYSA-N 0.000 claims 1
- 238000003860 storage Methods 0.000 abstract description 6
- 239000007853 buffer solution Substances 0.000 abstract description 2
- 230000010355 oscillation Effects 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 238000003828 vacuum filtration Methods 0.000 abstract 1
- 102000003929 Transaminases Human genes 0.000 description 31
- 230000003197 catalytic effect Effects 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 239000000758 substrate Substances 0.000 description 15
- 108090000340 Transaminases Proteins 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- 125000005594 diketone group Chemical group 0.000 description 9
- 230000008569 process Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
- 238000004132 cross linking Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 5
- 102000004882 Lipase Human genes 0.000 description 5
- 108090001060 Lipase Proteins 0.000 description 5
- 239000004367 Lipase Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 235000019421 lipase Nutrition 0.000 description 5
- ISYORFGKSZLPNW-UHFFFAOYSA-N propan-2-ylazanium;chloride Chemical compound [Cl-].CC(C)[NH3+] ISYORFGKSZLPNW-UHFFFAOYSA-N 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 5
- 229960004034 sitagliptin Drugs 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 125000003700 epoxy group Chemical group 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 229920002873 Polyethylenimine Polymers 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 239000007986 glycine-NaOH buffer Substances 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- -1 (NH 4 ) 2 SO 4 3g Chemical compound 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000012045 crude solution Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012526 feed medium Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C12N11/091—Phenol resins; Amino resins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y206/00—Transferases transferring nitrogenous groups (2.6)
- C12Y206/01—Transaminases (2.6.1)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
Definitions
- This application belongs to the technical field of enzyme engineering, and specifically relates to a method for preparing a highly stable immobilized enzyme.
- immobilized enzymes As important catalysts, enzymes have been widely used in food, pharmaceutical, chemical and other fields. Compared with free enzymes, immobilized enzymes have better process adaptability, that is, better heat resistance, reagent tolerance, convenient solid-liquid phase separation, and recyclability and reuse. Therefore, immobilized enzymes have become indispensable green catalysts in the field of modern industrial catalysis.
- Immobilized enzyme preparation methods generally include adsorption methods, covalent binding methods, cross-linking methods and embedding methods.
- the adsorption method uses the van der Waals force between the carrier and the enzyme molecule to combine, which can easily cause the enzyme to fall off during use
- the covalent binding method has the formation of a covalent bond between the carrier and the enzyme molecule, and the enzyme is not easy to use after multiple uses.
- Shedding uses protein cross-linking agents, such as glutaraldehyde, to form covalent bonds between enzyme molecules, thereby converting the free "monomeric enzyme” into a "polymeric enzyme” with a three-dimensional structure, thereby increasing the enzyme's stability.
- patent CN113308457 A discloses a method in which amino ligands react with aldehyde ligands under the protection of polyvinyl polypyrrolidone to form an organic skeleton and embed enzyme molecules in it. The operation is simple, but the preparation process involves the strong carcinogenic chemical diphenylamine. Participation is not conducive to production applications.
- the immobilization adaptability of different enzymes and carriers is optimized to improve Stability of immobilized enzymes.
- parameter optimization of the immobilization process such as selecting different resin types, enzyme and carrier ratios, etc.
- further chemical modification of the immobilized enzyme can also improve its stability. Hadjer Zaak et al.
- Chinese patent CN 111117996A discloses an immobilized enzyme, its preparation method and application.
- This method uses polyethylene glycol to modify glutaraldehyde or aldehyde-based dextran, and finally forms a network structure dispersed with aldehyde groups and hydroxyl groups.
- the enzyme is wrapped by covalent bonds, ionic bonds and other forces, thereby improving the mechanical stability of the enzyme.
- this process requires optimizing the ratio of aldehydes to polyethylene glycol, adding active groups to the polyethylene glycol molecules, and then forming covalent bonds with the groups on the enzyme protein.
- the improvement of mechanical stability depends on the polymerization of enzyme molecules. As well as the interaction between polyethylene glycol macromolecules and enzyme molecules, there is still much room for improvement in the stability of the enzyme molecule's own skeleton.
- Epoxy groups are more likely to undergo addition reactions with amino groups in proteins. When the number of epoxy groups is greater than 1, covalent bonds are formed between protein molecules and polymerization proceeds. Therefore, epoxy cross-linking agents are used in wool or silk processing, such as the spinning and film-making process of monomer polymerization after dissolution (Zhang Yurong, Liu Jianyong, Wang Jie. Ethylene glycol diglycidyl ether cross-linked wool keratin [J ]. Materials Herald, 2013, 27: 230-232.); is also used to prepare biomedical materials, such as molecular cross-linking of hemoglobin to obtain functional oligomers of hemoglobin in order to replace red blood cells.
- this application discloses a preparation method of high-stability immobilized enzymes, which improves the stability of the enzyme through the compound use of cross-linking agents.
- recombinant bacteria such as recombinant Escherichia coli
- buffer glycine-NaOH buffer
- centrifuge to take the supernatant to obtain a crude solution with a concentration of 4.5 ⁇ 9U/ml. enzyme solution
- the preparation method of the crude enzyme solution in this step is a conventional enzyme solution preparation method in this field, such as the method disclosed in the book "Wei Dongzhi "Enzyme Engineering” Higher Education Press, 2020”.
- the adding amount of long-range cross-linking agent is 2-6% of the volume of boric acid buffer; the adding amount of short-range cross-linking agent is 2-6% of the volume of LXTE-700S@enzyme solution, and the added long-range cross-linking agent
- the volumes of linking agent and short-range cross-linking agent cannot both be 6% of the volume of LXTE-700S@enzyme liquid.
- the long-range cross-linking agent is an epoxy-based cross-linking agent, which is polyethylene glycol diglycidyl ether (215); the short-range cross-linking agent is ethylene glycol diglycidyl ether (669), glycerol triglycidyl ether At least one of ether (633) and 1,6-hexanediol diglycidyl ether (632).
- the volume ratio of the added long-range cross-linking agent to the short-range cross-linking agent is 1:3 to 3:1, such as 1:1, 1:2, 1:3, 2:1 or 3:1.
- This application uses the two epoxy groups of polyethylene glycol diglycidyl ether to covalently bind to the enzyme protein in a buffer system prepared by conventional immobilized enzymes, and encapsulates them through the synergistic action of long-range and short-range epoxy cross-linking agents. It also strengthens the enzyme molecular skeleton, and at the same time, the short-range cross-linking agent forms intramolecular covalent bonds, further improving the stability of the enzyme molecular skeleton, significantly increasing the storage and service life of the immobilized enzyme, and the preparation method is simple and easy to promote and apply.
- Figure 1 is a diagram showing the storage stability comparison results of several immobilized enzymes in Examples.
- Figure 2 is a graph showing the results of 20 experiments comparing the catalytic efficiency of transaminase immobilized enzymes prepared by treatment with epoxy cross-linking agents.
- the raw materials and reagents used in the following examples are all commercially available, among which: the cross-linking agent polyethylene glycol diglycidyl ether (215) was purchased from Shanghai McLean Biochemical Technology Co., Ltd.; ethylene glycol diglycidyl ether (215) was purchased from Shanghai McLean Biochemical Technology Co., Ltd. 669), glycerol triglycidyl ether (633), and 1,6-hexanediol diglycidyl ether (632) were purchased from Guangzhou Yuanda New Materials Co., Ltd.;
- ETDuet-1 E. coli was purchased from Jiutian Gene.
- Fermentation medium 10g glucose, 15g yeast powder, 20g peptone, 10g NaCl, (NH 4 ) 2 SO 4 3g, K 2 HPO 4 ⁇ 3H 2 O 2.28g, KH 2 PO 4 1.36g, MgSO 4 2.0g, add water to make up to 1L.
- Feed medium 350g glycerol, 50g yeast extract, 50g peptone, add water to make up 1L.
- step (4) Take 2 ml of the culture obtained in step (4) and inoculate it into 200 ml of LB medium containing 100 ⁇ g/ml ampicillin, and culture it at 37°C and shaking at 250 rpm for 8 to 10 hours;
- step (6) The culture obtained in step (5) is used as a seed and inoculated into 5L fermentation medium containing 100 ⁇ g/ml ampicillin.
- the DO value is constant at 25%. Stir and DO are linked. Cultivate for 5 hours. After the pH value rises, the index is supplemented. When the fermentation is completed in 26 to 28 hours, the wet weight of the cells will be 200 to 250g/L.
- the engineering bacteria involved in this example were constructed using conventional methods in the field, such as the methods disclosed in the reference book “Sam Brooke's “Molecular Cloning Experiment Guide,” Fourth Edition, Volume 1. Science Press, 2017.
- step (2) Add the wet bacterial cells obtained in step (1) to 0°C pre-cooled pH 9.0 glycine-NaOH buffer at a mass-to-volume ratio of 1:10, and resuspend the bacterial cells to prepare a bacterial suspension;
- step (2) the bacterial suspension is placed in an ultrasonic crusher to crush the bacterial cells to obtain a homogenate of the bacterial cells;
- step (3) The bacterial homogenate in step (3) was centrifuged at 4°C and 9000g for 10 minutes, and the supernatant was collected to obtain a crude transaminase enzyme solution with a transaminase concentration of 4.5 U/ml (in specific embodiments, the enzyme solution was prepared according to a conventional method Preparation, the concentration is within the range of 4.5-9U/ml, and the purpose of application can be achieved.)
- the above method for preparing crude aminotransferase enzyme solution is a conventional method in this field.
- step (3) The precipitated Buchner funnel of step (2) is suction-filtered to obtain four types of immobilized aminotransferases using different resins as carriers for catalytic experiments;
- the mobile phase elutes isocratic, detection wavelength: 205nm, flow rate: 1.0ml/min, column temperature: 30°C, the same below) and calculate the substrate conversion rate (product peak area/(product peak area + substrate peak area)*100%, the same below) after measurement.
- the results are shown in Table 1.
- the resulting immobilized enzyme was named: LXTE-700S@transaminase and was used for subsequent experiments.
- step (3) Add 2ml, 4ml, 6ml, 8ml, 10ml and 12ml of cross-linking agents polyethylene glycol diglycidyl ether (215) and ethylene glycol diglycidyl (669) to the 24 systems obtained in step (2) respectively. , glycerol triglycidyl ether (633) and 1,6-hexanediol diglycidyl ether (632);
- step (3) The system obtained in step (3) is incubated with shaking at 37°C for 2.5 hours, then filtered and washed with at least 50 ml of pure water to obtain the immobilized enzyme;
- LXTE-700S@transaminase is treated with 2% to 6% cross-linking agent 215 or 2% to 6% cross-linking agent 633, its catalytic conversion rate is greater than 90%.
- LXTE-700S@transaminase treated with 6% cross-linking agent 215 and 6% cross-linking agent 633 are named: LXTE-700S@transaminase@215 and LXTE-700S@transaminase@633 respectively.
- LXTE-700S@transaminase, LXTE-700S@transaminase@215, LXTE-700S@transaminase@633 and LXTE-700S@transaminase@215-633 were placed at room temperature, 4°C and -20°C for 30 days respectively;
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Procédé de préparation d'une enzyme immobilisée stable. Le procédé consiste à ajouter la résine aminée LXTE-700S dans une solution d'enzyme brute pour la filtrer, puis à ajouter une solution tampon d'acide borique et du phosphate de pyridoxal, et à effectuer une réaction d'oscillation; et enfin, à ajouter un agent de réticulation à longue portée et un agent de réticulation à courte portée, à effectuer une réaction d'oscillation, puis à effectuer une filtration sous vide pour obtenir l'enzyme immobilisée présentant une forte stabilité. L'agent de réticulation à base d'époxy est un mélange d'un agent de réticulation à longue portée de l'éther diglycidylique du polyéthylène glycol et d'un agent de réticulation à courte portée de l'éther triglycidylique du glycérol. Le procédé de préparation de l'enzyme immobilisée comporte des étapes simples et permet de prolonger sensiblement la durée de stockage et d'utilisation de l'enzyme immobilisée.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210330110.9 | 2022-03-28 | ||
CN202210330110.9A CN114657170B (zh) | 2022-03-28 | 2022-03-28 | 一种高稳定性固定化酶的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023186186A1 true WO2023186186A1 (fr) | 2023-10-05 |
Family
ID=82033886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2023/095548 WO2023186186A1 (fr) | 2022-03-28 | 2023-05-22 | Procédé de préparation d'une enzyme immobilisée ayant une forte stabilité |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114657170B (fr) |
WO (1) | WO2023186186A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114657170B (zh) * | 2022-03-28 | 2023-04-07 | 安庆朗坤药业有限公司 | 一种高稳定性固定化酶的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110964710A (zh) * | 2019-12-25 | 2020-04-07 | 吉林凯莱英医药化学有限公司 | 固定化酶、其制备方法及其应用 |
WO2021128086A1 (fr) * | 2019-12-25 | 2021-07-01 | 吉林凯莱英医药化学有限公司 | Enzyme immobilisée, procédé de préparation et application associés |
CN113817699A (zh) * | 2021-09-28 | 2021-12-21 | 凯莱英医药集团(天津)股份有限公司 | 转氨酶突变体及其应用 |
CN114657170A (zh) * | 2022-03-28 | 2022-06-24 | 安庆朗坤药业有限公司 | 一种高稳定性固定化酶的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110241107A (zh) * | 2019-06-11 | 2019-09-17 | 中国科学院南海海洋研究所 | 一种使用氨基树脂固定化脂肪酶的方法及由该方法制得的固定化脂肪酶 |
-
2022
- 2022-03-28 CN CN202210330110.9A patent/CN114657170B/zh active Active
-
2023
- 2023-05-22 WO PCT/CN2023/095548 patent/WO2023186186A1/fr unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110964710A (zh) * | 2019-12-25 | 2020-04-07 | 吉林凯莱英医药化学有限公司 | 固定化酶、其制备方法及其应用 |
WO2021128086A1 (fr) * | 2019-12-25 | 2021-07-01 | 吉林凯莱英医药化学有限公司 | Enzyme immobilisée, procédé de préparation et application associés |
CN113817699A (zh) * | 2021-09-28 | 2021-12-21 | 凯莱英医药集团(天津)股份有限公司 | 转氨酶突变体及其应用 |
CN114657170A (zh) * | 2022-03-28 | 2022-06-24 | 安庆朗坤药业有限公司 | 一种高稳定性固定化酶的制备方法 |
Non-Patent Citations (1)
Title |
---|
MINGHUA QIAN, ZHANG JIFU, ZHANG YUN, SUN AIJUN, YU RONGMIN: "Immobilization of lipase on macroporous resin by adsorption-crosslinking method ", JOURNAL OF SOUTH CHINA AGRICULTURAL UNIVERSITY, CN, vol. 40, no. 2, 30 January 2019 (2019-01-30), CN , pages 103 - 110, XP093095373, ISSN: 1001-411X, DOI: 10.7671/j.issn.1001-411X.201804031 * |
Also Published As
Publication number | Publication date |
---|---|
CN114657170B (zh) | 2023-04-07 |
CN114657170A (zh) | 2022-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11535839B2 (en) | Encoding genes of nitrilase mutants and application thereof | |
WO2023186186A1 (fr) | Procédé de préparation d'une enzyme immobilisée ayant une forte stabilité | |
JP7105307B2 (ja) | トランスアミナーゼ突然変異体及びその応用 | |
CN108384767A (zh) | 转氨酶突变体及其应用 | |
CN106978368B (zh) | 解鸟氨酸拉乌尔菌及其应用 | |
US11987826B2 (en) | Nitrilase mutant and application thereof in the synthesis of an anti-epileptic drug intermediate | |
CN105624128B (zh) | 一种固定化单胺氧化酶及其在合成手性氮杂双环化合物中的应用 | |
EP3533862B1 (fr) | Methylopila sp. et utilisation associée dans la résolution sélective et la préparation d'acétate de (s)-alpha-éthyl-2-oxo-1-pyrrolidine | |
Cabirol et al. | Linum usitatissimum hydroxynitrile lyase cross‐linked enzyme aggregates: a recyclable enantioselective catalyst | |
Zhang et al. | Novel biocatalytic strategy of levan: His-ELP-intein-tagged protein purification and biomimetic mineralization | |
CN116640742A (zh) | 一种酸性磷酸酶突变体、其应用及其制备烟酰胺核糖的方法 | |
CN113817699B (zh) | 转氨酶突变体及其应用 | |
CN109593739B (zh) | 重组酮酸还原酶突变体、基因、工程菌及其应用 | |
CN113322291A (zh) | 一种手性氨基醇类化合物的合成方法 | |
CN112779243A (zh) | 一种L-天冬氨酸-α-脱羧酶及其应用 | |
CN117778371B (zh) | 苯丙酮酸脱羧酶和醇脱氢酶的共固定化酶、制备及应用 | |
US20220204953A1 (en) | Mutant of Acid Phosphatase and Application Thereof | |
CN107118977B (zh) | 粘质沙雷氏菌及其应用 | |
CN116574704A (zh) | 醛酮还原酶-葡萄糖脱氢酶共固定化酶及在他汀类药物手性中间体连续流合成中的应用 | |
CN116814574A (zh) | 一种亚胺还原酶突变体、重组基因工程菌及其在(r)-2-甲基吡咯烷合成中的应用 | |
JP2008061501A (ja) | 遊離カルボン酸・アミンの直接縮合反応を触媒する酵素の設計方法及びナイロンオリゴマーの酵素的製造方法 | |
CN117025582A (zh) | 一种固定醛缩酶的方法 | |
CN117867050A (zh) | 一种体外多酶级联催化合成丁内酰胺的方法 | |
CN104694543A (zh) | 特异性识别β-葡萄糖醛酸苷酶的核酸适配体序列及其应用 | |
CN116987650A (zh) | 一种产四氢嘧啶的嗜甲烷工程菌及其构建方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23778548 Country of ref document: EP Kind code of ref document: A1 |